HKSE - Delayed Quote HKD
VIVA BIOTECH (1873.HK)
1.480
-0.030
(-1.99%)
At close: April 25 at 4:08:21 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,986,651
1,986,651
2,155,578
2,379,631
2,104,083
Cost of Revenue
1,299,252
1,299,252
1,417,146
1,563,952
1,453,102
Gross Profit
687,399
687,399
738,432
815,679
650,981
Operating Expense
417,810
417,810
482,307
503,818
381,147
Operating Income
269,589
269,589
256,125
311,861
269,834
Net Non Operating Interest Income Expense
-33,353
-33,353
-149,207
-163,068
-156,533
Pretax Income
295,705
295,705
-55,953
-459,165
347,701
Tax Provision
73,718
73,718
43,837
45,055
47,141
Net Income Common Stockholders
167,294
167,294
-116,113
-528,475
287,546
Average Dilution Earnings
--
--
-174,323
--
-124,742
Diluted NI Available to Com Stockholders
167,294
167,294
-290,436
-528,475
162,804
Basic EPS
0.08
0.08
-0.06
-0.28
0.15
Diluted EPS
0.06
0.06
-0.14
-0.28
0.08
Basic Average Shares
2,136,664
2,136,664
1,940,474
1,915,437
1,911,530
Diluted Average Shares
2,868,364
2,868,364
2,028,679
1,915,437
1,970,799
Total Expenses
1,717,062
1,717,062
1,899,453
2,067,770
1,834,249
Net Income from Continuing & Discontinued Operation
167,294
167,294
-116,113
-528,475
287,546
Normalized Income
133,524.320
133,524.320
91,111.900
-163,728.050
229,407.646
Interest Income
20,539
20,539
27,375
21,606
26,575
Interest Expense
53,892
53,892
176,582
184,674
183,108
Net Interest Income
-33,353
-33,353
-149,207
-163,068
-156,533
EBIT
349,597
349,597
120,629
-274,491
530,809
EBITDA
563,458
563,458
331,845
-89,037
683,963
Reconciled Cost of Revenue
1,299,252
1,299,252
1,417,146
1,563,952
1,453,102
Reconciled Depreciation
213,861
213,861
211,216
185,454
153,154
Net Income from Continuing Operation Net Minority Interest
167,294
167,294
-116,113
-528,475
287,546
Total Unusual Items Excluding Goodwill
44,984
44,984
-262,310
-461,705
67,257
Total Unusual Items
44,984
44,984
-262,310
-461,705
67,257
Normalized EBITDA
518,474
518,474
594,155
372,668
616,706
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
11,214.320
11,214.320
-55,085.100
-96,958.050
9,118.646
12/31/2021 - 5/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1877.HK JUNSHI BIO
15.420
-3.50%
9966.HK Alphamab Oncology
6.910
-0.43%
2410.HK TYK Medicines, Inc
27.500
0.00%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
293.800
-4.67%
9688.HK Zai Lab Limited
25.650
-1.16%
2157.HK Lepu Biopharma Co., Ltd.
4.350
-3.97%
9995.HK RemeGen Co., Ltd.
43.450
+5.08%
2142.HK HBM Holdings Limited
8.210
+3.40%
1952.HK Everest Medicines Limited
47.400
+2.16%
2696.HK Shanghai Henlius Biotech, Inc.
37.850
-2.82%